Mar 30, 4:16 AM EDT
Everything You Need To Know, Right Now.
Stay connected to the biggest stories unfolding in technology.
The IBTech Newsletter keeps you connected to the biggest stories unfolding in technology.
Please enter a valid email
Media & Culture
Novartis Clinches Alcon In $12.9 Bln Deal
on 12/15/10 AT 10:11 AM
Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
Alcon squeeze-out bitter pill for minority holders
By IBT Staff Reporter on 01/05/10 AT 1:40 PM
Swiss drugmaker Novartis (NOVN.VX) is taking a rare stance in the M&A world by lowballing Alcon's minority shareholders.